LXRX · Categories · Form 4

LXRX - SEC Form 4 insider transactions

Lexicon Pharmaceuticals Inc. (LXRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LXRX

• 6d
  Director Swain Judith L converted options into 89,312 shares, increasing direct ownership by 105% to 174,486 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Sullivan Diane E. converted options into 89,312 shares, increasing direct ownership by 243% to 126,122 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Sobecki Christopher J converted options into 89,312 shares, increasing direct ownership by 44% to 293,177 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Cheung Ivan converted options into 89,312 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Amouyal Philippe converted options into 89,312 shares, increasing direct ownership by 31% to 374,486 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Barker Sam L converted options into 89,312 shares, increasing direct ownership by 72% to 213,771 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 6d
  Director Debbane Raymond converted options into 89,312 shares, increasing direct ownership by 5% to 1,995,498 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 32d
  Director Artal Participations S.A R.L. converted options into 20,421,735 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 36d
  SEC Form 4 filed by Director Amouyal Philippe

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 36d
  SEC Form 4 filed by Director Sobecki Christopher J

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 37d
  SEC Form 4 filed by Director Barker Sam L

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 37d
  SEC Form 4 filed by Director Cheung Ivan

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 37d
  SEC Form 4 filed by Director Swain Judith L

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 37d
  SEC Form 4 filed by Director Sullivan Diane E.

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 37d
  SEC Form 4 filed by Director Debbane Raymond

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, Human Resources Mcdermott Wendy converted options into 224,406 shares and covered exercise/tax liability with 68,107 shares, increasing direct ownership by 128% to 277,945 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, Partnerships & Corp Strat Martens Rachel Yap converted options into 67,090 shares and covered exercise/tax liability with 35,826 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, Chief Medical Officer Granowitz Craig B converted options into 312,276 shares and covered exercise/tax liability with 109,098 shares, increasing direct ownership by 169% to 323,430 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, Discovery Gopinathan Suma converted options into 99,950 shares and covered exercise/tax liability with 24,338 shares, increasing direct ownership by 101% to 150,132 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, IR and Corp Comm Defrancesco Lisa converted options into 152,864 shares and covered exercise/tax liability with 74,572 shares, increasing direct ownership by 503% to 93,869 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, General Counsel & Secr. Crum Brian T converted options into 273,006 shares and covered exercise/tax liability with 105,019 shares, increasing direct ownership by 30% to 428,802 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  SVP, Chief Financial Officer Coiante Scott M covered exercise/tax liability with 54,881 shares and converted options into 160,237 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 99d
  Chief Executive Officer Exton Michael covered exercise/tax liability with 204,831 shares and converted options into 503,263 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 110d
  Director Artal Participations S.A R.L. was granted 41,290 units of Series B Convertible Preferred Stock (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, Human Resources Mcdermott Wendy

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, Partnerships & Corp Strat Martens Rachel Yap

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, Chief Medical Officer Granowitz Craig B

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, Discovery Gopinathan Suma

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, IR and Corp Comm Defrancesco Lisa

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, General Counsel & Secr. Crum Brian T

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by SVP, Chief Financial Officer Coiante Scott M

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 112d
  SEC Form 4 filed by Chief Executive Officer Exton Michael

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Swain Judith L

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Sullivan Diane E.

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Sobecki Christopher J

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Cheung Ivan

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Barker Sam L

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Amouyal Philippe

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 372d
  SEC Form 4 filed by Director Debbane Raymond

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Swain Judith L converted options into 36,810 shares, increasing direct ownership by 76% to 85,174 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Sullivan Diane E. converted options into 36,810 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Sobecki Christopher J converted options into 36,810 shares, increasing direct ownership by 22% to 203,865 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Barker Sam L converted options into 36,810 shares, increasing direct ownership by 42% to 124,459 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Amouyal Philippe converted options into 36,810 shares, increasing direct ownership by 15% to 285,174 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 392d
  Director Debbane Raymond converted options into 36,810 shares, increasing direct ownership by 3% to 1,385,689 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  VP, Finance and Accounting Alexander Kristen converted options into 46,430 shares and covered exercise/tax liability with 17,862 shares, increasing direct ownership by 60% to 76,368 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  SVP, Human Resources Mcdermott Wendy covered exercise/tax liability with 30,004 shares and converted options into 98,956 shares, increasing direct ownership by 131% to 121,646 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  EVP, Innov & Chem Sciences Main Alan J converted options into 126,814 shares and covered exercise/tax liability with 43,434 shares, increasing direct ownership by 33% to 339,104 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  SVP, Chief Medical Officer Granowitz Craig B converted options into 137,934 shares and covered exercise/tax liability with 65,308 shares, increasing direct ownership by 152% to 120,252 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  SVP, IR and Corp Comm Defrancesco Lisa converted options into 24,673 shares and covered exercise/tax liability with 9,096 shares (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 463d
  SVP, General Counsel & Secr. Crum Brian T converted options into 128,940 shares and covered exercise/tax liability with 45,622 shares, increasing direct ownership by 47% to 260,815 units (SEC Form 4)

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by VP, Finance and Accounting Alexander Kristen

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by SVP, Human Resources Mcdermott Wendy

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by EVP, Innov & Chem Sciences Main Alan J

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by SVP, Chief Medical Officer Granowitz Craig B

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by VP, IR and Corp Comm Defrancesco Lisa

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by SVP, General Counsel & Secr. Crum Brian T

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by SVP, Regulatory & QA Corrigan Brian

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by SVP, Chief Financial Officer Coiante Scott M

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
• 476d
  SEC Form 4 filed by Chief Executive Officer Exton Michael

  4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

Other LXRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends